Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics,...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SEOUL, South Korea, May 30, 2021 /PRNewswire-AsiaNet/ -- - Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American n...
Authors: LATEST ASIANET NEWS RELEASES